PYRIDINE AND PYRAZINE DERIVATIVES AS PREFERENTIAL CANNABINOID 2 AGONISTS
申请人:F. Hoffmann-La Roche AG
公开号:EP3814337A1
公开(公告)日:2021-05-05
[EN] PYRIDINE AND PYRAZINE DERIVATIVES AS PREFERENTIAL CANNABINOID 2 AGONISTS<br/>[FR] DÉRIVÉS DE PYRIDINE ET DE PYRAZINE EN TANT QU'AGONISTES DE CANNABINOÏDE 2 PRÉFÉRENTIELS
申请人:HOFFMANN LA ROCHE
公开号:WO2020002270A1
公开(公告)日:2020-01-02
The invention relates to a compound of formula (I), wherein A1, A2 and R1-R5 are as defined in the description and in the claims. The compound of formula (I) can be used as cannabinoid 2 preferential agonist.